Recurrence and bleeding in the extended treatment of patients with pulmonary embolism (PE) and cancer Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018
Analysis of long-term survival of patients diagnosed of pulmonary embolism (PE) Source: Annual Congress 2006 - Pulmonary embolism Year: 2006
Effect of statin therapy in patients with lung cancer on mortality, incidence of infections and pulmonary embolism Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012
1 year clinical follow-up of patients affected by acute pulmonary embolism (PE) Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005
Efficacy of age adjusted d-dimer in excluding pulmonary embolism in patients with cancer. Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism Year: 2020
Postoperative morbidity and mortality after pneumonectomy (PE) in pulmonary tuberculosis (TB) patients: a 5-year experience Source: International Congress 2019 – Thoracic surgery Year: 2019
The analysis of lung cancer patients (LCP) survival during 5 year period after diagnosis of disease Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
Silent venous thromboembolism (VTE) in patients undergoing thoracic surgery in the course of lung cancer. Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
The incidence of serious venous thromboembolic events in 1157 lung cancer patients Source: Annual Congress 2008 - Diagnosis and prognosis in thoracic oncology Year: 2008
Mortality and recurrence during a follow-up of 2 years of pulmonary embolism: Role of anticoagulant therapy Source: Annual Congress 2010 - Pulmonary embolism Year: 2010
Follow-up and surveillance for lung cancer Source: Annual Congress 2005 - MP5 - Follow-up and surveillance for lung cancer Year: 2005
Frequency of thromboembolic events in patients with lung cancer at the time of diagnosis and in the course of disease Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011
The analysis of lung cancer patients (LCP) survival during one-year period after diagnosing of disease Source: Eur Respir J 2006; 28: Suppl. 50, 88s Year: 2006
The analysis of pulmonary tromboembolism (PTE) in structure of mortality of therapeutic and surgical patients Source: Eur Respir J 2007; 30: Suppl. 51, 603s Year: 2007
Risk quantification for postoperative pulmonary complications after pulmonary resection in lung cancer patients Source: Annual Congress 2008 - Risk assessment and treatment of complications in thoracic surgery patients Year: 2008
Lung cancer surgery: 30-day survival and complications in an unselected population Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery Year: 2008
Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients. Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies Year: 2018
5 year survival of patients with distal chronic thromoembolic pulmonary hypertension; comparison of treated patients with distal disease and residual disease post pulmonary endartectomy Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease Year: 2010
Long-term follow-up of the ISOLDE participants: causes of death after 13 years of the trial completion Source: Annual Congress 2007 - Nurses' involvement in the follow-up of patients with COPD and lung cancer Year: 2007
Five cases of breast cancer complicated with pulmonary embolism Source: Eur Respir J 2006; 28: Suppl. 50, 45s Year: 2006